Related references
Note: Only part of the references are listed.Molecular Pathogenesis of Cholangiocarcinoma
Peter L. Labib et al.
BMC CANCER (2019)
Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan et al.
LIVER INTERNATIONAL (2019)
Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles
Niyaz Ahmad et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review
Omar Abdifetah et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options
Carlo Felix Maria Jung et al.
ONCOLOGY (2019)
Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells
Vivek B. Mathema et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Cytotoxic activities and effects of atractylodin and β-eudesmol on the cell cycle arrest and apoptosis on cholangiocarcinoma cell line
Kanawut Kotawong et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes
Santwana Padhi et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2018)
Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application
Yanchun Wei et al.
NANOMEDICINE (2018)
Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid
Isabela Angeli de Lima et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis
Jennifer A. Steele et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics
Kesara Na-Bangchang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
Pedram Rafiei et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles
Madhwi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease
Niyaz Ahmad
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2017)
Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy
Vaibhav Khare et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
Huijuan Zhang et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2016)
Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model
Tullayakorn Plengsuriyakarn et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC.
Nut Koonrungsesomboon et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2014)
Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs
Martin J. Wolfsegger et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
Share Paper
